These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 1562049)
1. Mast-cell phenotype in indolent forms of mastocytosis. Ultrastructural features, fluorescence detection of avidin binding, and immunofluorescent determination of chymase, tryptase, and carboxypeptidase. Weidner N; Horan RF; Austen KF Am J Pathol; 1992 Apr; 140(4):847-57. PubMed ID: 1562049 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content. Weidner N; Austen KF Pathol Res Pract; 1993 Mar; 189(2):156-62. PubMed ID: 8321743 [TBL] [Abstract][Full Text] [Related]
3. Mast cells expressing chymase but not tryptase can be derived by culturing human progenitors in conditioned medium obtained from a human mastocytosis cell strain with c-kit ligand. Li L; Meng XW; Krilis SA J Immunol; 1996 Jun; 156(12):4839-44. PubMed ID: 8648132 [TBL] [Abstract][Full Text] [Related]
5. Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study. Horny HP; Greschniok A; Jordan JH; Menke DM; Valent P J Clin Pathol; 2003 Feb; 56(2):103-6. PubMed ID: 12560387 [TBL] [Abstract][Full Text] [Related]
6. Human mast cells arise from a common circulating progenitor. Maaninka K; Lappalainen J; Kovanen PT J Allergy Clin Immunol; 2013 Aug; 132(2):463-9.e3. PubMed ID: 23582567 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis. Kurosawa M; Amano H; Kanbe N; Akimoto S; Takeuchi Y; Yamashita T; Hashimoto T; Kurimoto F; Miyachi Y J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S25-32. PubMed ID: 9440541 [TBL] [Abstract][Full Text] [Related]
8. Protease profile of normal and neoplastic mast cells in the human bone marrow with special emphasis on systemic mastocytosis. Atiakshin D; Buchwalow I; Horny P; Tiemann M Histochem Cell Biol; 2021 May; 155(5):561-580. PubMed ID: 33492488 [TBL] [Abstract][Full Text] [Related]
9. Ultrastructural and immunohistochemical characterization of normal mast cells at multiple body sites. Weidner N; Austen KF J Invest Dermatol; 1991 Mar; 96(3 Suppl):26S-30S; discussion 30S-31S, 60S-65S. PubMed ID: 16799605 [TBL] [Abstract][Full Text] [Related]
10. Mastocytosis: state of the art. Horny HP; Sotlar K; Valent P Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883 [TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema. Järvikallio A; Naukkarinen A; Harvima IT; Aalto ML; Horsmanheimo M Br J Dermatol; 1997 Jun; 136(6):871-7. PubMed ID: 9217819 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Horny HP; Sillaber C; Menke D; Kaiserling E; Wehrmann M; Stehberger B; Chott A; Lechner K; Lennert K; Valent P Am J Surg Pathol; 1998 Sep; 22(9):1132-40. PubMed ID: 9737247 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms. Valent P; Sperr WR; Schwartz LB; Horny HP J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337 [TBL] [Abstract][Full Text] [Related]
14. Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation. Akimoto S; Ishikawa O; Igarashi Y; Kurosawa M; Miyachi Y Br J Dermatol; 1998 Mar; 138(3):399-406. PubMed ID: 9580789 [TBL] [Abstract][Full Text] [Related]
15. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease. Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914 [TBL] [Abstract][Full Text] [Related]
16. Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase. Goldstein SM; Leong J; Schwartz LB; Cooke D J Immunol; 1992 Apr; 148(8):2475-82. PubMed ID: 1560203 [TBL] [Abstract][Full Text] [Related]
17. Human MCTC type of mast cell granule: the uncommon occurrence of discrete scrolls associated with focal absence of chymase. Craig SS; Schwartz LB Lab Invest; 1990 Oct; 63(4):581-5. PubMed ID: 2232709 [TBL] [Abstract][Full Text] [Related]
18. Ultrastructural and immunohistochemical characterization of normal mast cells at multiple body sites. Weidner N; Austen KF J Invest Dermatol; 1991 Mar; 96(3):26S-30S; discussion 30S-31S. PubMed ID: 2002249 [TBL] [Abstract][Full Text] [Related]
19. Co-localization of tryptase and cathepsin-G in mast cells in cutaneous mastocytosis. Ribatti D; Nico B; Finato N; Crivellato E; Beltrami CA Cancer Lett; 2009 Jul; 279(2):209-12. PubMed ID: 19250736 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L). Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]